Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer

Although intravesical gemcitabine (GEM) chemotherapy (IGC) can effectively reduce the recurrence risk of non-muscle invasive bladder cancer (NMIBC), the development of GEM resistance may occur and result in cancer recurrence and disease progression. Herein, a label-free proteomics approach was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Shiyu, Yin, Hongling, Fu, Jun, Li, Yangle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899363/
https://www.ncbi.nlm.nih.gov/pubmed/35281857
http://dx.doi.org/10.7150/jca.66248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899363/
https://www.ncbi.nlm.nih.gov/pubmed/35281857
http://dx.doi.org/10.7150/jca.66248

Ejemplares similares